These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25420655)

  • 1. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus.
    Shirasago Y; Sekizuka T; Saito K; Suzuki T; Wakita T; Hanada K; Kuroda M; Abe R; Fukasawa M
    Jpn J Infect Dis; 2015; 68(2):81-8. PubMed ID: 25420655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection.
    Akazawa D; Date T; Morikawa K; Murayama A; Miyamoto M; Kaga M; Barth H; Baumert TF; Dubuisson J; Wakita T
    J Virol; 2007 May; 81(10):5036-45. PubMed ID: 17329343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
    Li YP; Ramirez S; Mikkelsen L; Bukh J
    J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different responses of two highly permissive cell lines upon HCV infection.
    Chen H; Pei R; Chen X
    Virol Sin; 2013 Aug; 28(4):202-8. PubMed ID: 23818110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrifugal enhancement of hepatitis C virus infection of human hepatocytes.
    Ye L; Wang X; Wang S; Luo G; Wang Y; Liang H; Ho W
    J Virol Methods; 2008 Mar; 148(1-2):161-5. PubMed ID: 18178263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
    Shirasago Y; Fukazawa H; Aizaki H; Suzuki T; Suzuki T; Sugiyama K; Wakita T; Hanada K; Abe R; Fukasawa M
    J Gen Virol; 2018 Oct; 99(10):1407-1417. PubMed ID: 30045785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
    Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
    Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of HCV particles from serum-free culture.
    Akazawa D; Morikawa K; Omi N; Takahashi H; Nakamura N; Mochizuki H; Date T; Ishii K; Suzuki T; Wakita T
    Vaccine; 2011 Jun; 29(29-30):4821-8. PubMed ID: 21550372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
    Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
    J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
    Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
    J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
    Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
    J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mebiolgel, a thermoreversible polymer as a scaffold for three dimensional culture of Huh7 cell line with improved hepatocyte differentiation marker expression and HCV replication.
    Rajalakshmy AR; Malathi J; Madhavan HN; Samuel JK
    Indian J Med Microbiol; 2015; 33(4):554-9. PubMed ID: 26470963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tree shrew bone marrow-derived mesenchymal stem cells express CD81, OCLN, and miR-122, facilitating the entire hepatitis C virus life cycle.
    Lu C; Feng Y; Sun X; Li N; Kuang D; Wang W; Tong P; Han Y; Xia X; Dai J
    J Med Virol; 2020 Dec; 92(12):3465-3474. PubMed ID: 32056224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
    Shirasago Y; Shimizu Y; Tanida I; Suzuki T; Suzuki R; Sugiyama K; Wakita T; Hanada K; Yagi K; Kondoh M; Fukasawa M
    Biol Pharm Bull; 2016 May; 39(5):839-48. PubMed ID: 26887345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
    Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
    Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I.
    Feigelstock DA; Mihalik KB; Kaplan G; Feinstone SM
    Virol J; 2010 Feb; 7():44. PubMed ID: 20170495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.